LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Liquidia Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$34.13−0.22 (-0.64%)
Close on Oct 19, 2026
- Market cap
- $3.46B
- P/E (TTM)
- 24.6
- Dividend yield
- –
Share price
+$11.65 (+51.82%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Liquidia Corp grew revenue 2233.6% to $450.91M over the twelve months to Jun 30, 2026. Free cash flow was $150.69M.
Revenue
$450.91M
+2233.6% vs. a year earlier
Operating income
$168.58M
TTM Q2 2026
Free cash flow
$150.69M
TTM Q2 2026
EPS, diluted
$1.39
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.46B
- P/E ratio
- 24.6
- Price to sales
- 7.67
- Price to book
- 17.74
- Dividend yield
- –
- Free cash flow yield
- 4.35%
Fundamentals
- Revenue
- $450.91M
- Net income
- $138.61M
- EPS, diluted
- $1.39
- Free cash flow
- $150.69M
- Book value per share
- $1.92
- Diluted shares
- 101M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$450.91M+2233.6% YoY
Gross profit
–
Operating income
$168.58M
Net income
$138.61M
EPS, diluted
$1.39
Free cash flow
$150.69M
Reported periodTrailing twelve months